Press release
Insights on the Transmembrane Prolyl 4 Hydroxylase Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global transmembrane prolyl 4 hydroxylase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Transmembrane prolyl 4-hydroxylase (P4H-TM) is a member of the P4H family. Additionally, biallelic loss of function P4H-TM mutations causes a syndromic form of severe cognitive impairment in humans. The major factor driving the demand for transmembrane prolyl 4 hydroxylase market is the increasing prevalence of colitis across the globe.According to the National Center for Biotechnology Information (NCBI), ulcerative colitis has an incidence rate of 9 to 20 cases per 100,000 persons per year globally. Additionally, its prevalence is 156 to 291 cases per 100,000 persons per year across the globe. Furthermore, it has a greater prevalence in adults compared to Crohn's disease. Hence, the increasing prevalence of colitis is driving the demand for transmembrane prolyl 4 hydroxylase.
To Request a Sample of our Report on Transmembrane Prolyl 4 Hydroxylase Market: https://www.omrglobal.com/request-sample/transmembrane-prolyl-4-hydroxylase-market
Moreover, North America hold a prominent share in the market owing to the presence of an advanced healthcare infrastructure as well as the presence of key players in the region. Additionally, the market is also growing due to the increasing application of transmembrane prolyl 4 hydroxylase in several diseases such as inflammatory bowel disease, among others. Some major players in the market include Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.
Market Coverage
· The market number available for - 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Type
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Transmembrane Prolyl 4 Hydroxylase Market is Available @ https://www.omrglobal.com/industry-reports/transmembrane-prolyl-4-hydroxylase-market
Global Transmembrane Prolyl 4 Hydroxylase Market Report by Segment
By Type
• Daprodustat
• Dimethyloxalylglycine
• FG-22216
• FG-4497
• Others
By Application
• Anemia
• Inflammatory Bowel Dosease
• Brain
• Edema
• Colitis
• Others
Global Transmembrane Prolyl 4 Hydroxylase Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Transmembrane Prolyl 4 Hydroxylase Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027 here
News-ID: 2576380 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Transmembrane
Transmembrane Prolyl 4 Hydroxylase Market Is Booming Worldwide | Latest Study Re …
The Transmembrane Prolyl 4 Hydroxylase market was valued at approximately USD 930 million in 2023 and is projected to reach around USD 2.8 billion by 2033, growing at a CAGR of about 11.6% from 2024 to 2033.
Transmembrane Prolyl 4 Hydroxylase Market Overview
Growth is underpinned by rising demand for collagen-based biomaterials and therapeutic proteins, especially in wound healing, anti-aging skincare, and regenerative medicine applications. Technological advancements in recombinant enzyme production…
Pioneering Precision: Navigating the Global Transmembrane Prolyl 4 Hydroxylase M …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
In the realm of molecular biology and biotechnology, transmembrane prolyl 4 hydroxylase (TP4H) plays a pivotal role in cellular processes, particularly in the post-translational modification of proteins. As research advances, the significance of TP4H in various applications, from drug discovery to therapeutic interventions, becomes increasingly apparent. In this blog, we explore the dynamic landscape of the global TP4H market, analyzing its size, share, and the impact of COVID-19, while dissecting…
Cystic Fibrosis Transmembrane Conductance Regulator Market Revolutionary Trends, …
MarketsandResearch.biz has newly added a research report titled Cystic Fibrosis Transmembrane Conductance Regulator Market 2023 is a detailed and dedicated analysis of the present scenario of the market covering the various aspects applicable to business growth. The report evaluates the market, putting forth all-inclusive data that enriches the scope, understanding, and application of this report. The report encompasses the information on the global Cystic Fibrosis Transmembrane Conductance Regulator market's status.…
Transmembrane Protein Market: Opportunities and Challenges for Market Players | …
Transmembrane protein market was valued at USD 2.8 billion in 2023 and is expected to reach USD 4.8 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028.
The Transmembrane Protein market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent…
Rising Demand for Transmembrane Prolyl 4 Hydroxylase Market Key Players, Growth …
Transmembrane prolyl 4 hydroxylase market is anticipated to grow at a significant CAGR during the forecast period. Transmembrane prolyl 4-hydroxylase (P4H-TM) is a member of the P4H family. Additionally, biallelic loss of function P4H-TM mutations causes a syndromic form of severe cognitive impairment in humans. The major factor driving the demand for transmembrane prolyl 4 hydroxylase market is the increasing prevalence of colitis across the globe.
According to the National…
Transmembrane Protein Market Size, Top Vendors, Industry Research and End User A …
LOS ANGELES, United States: The global Transmembrane Protein market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain strong growth in future. The report is compiled by subject matter experts and experienced market analysts, which makes it highly authentic and reliable. Readers are provided with deep analysis of historical and future market scenarios to get sound…
